March 6, 2018
Novartis’ Xoliar recommended as add-on therapy for chronic spontaneous urticaria for patients unresponsive to antihistamines
Novartis’ Xolair has been recommended in new global chronic urticaria guideline, the company noted Tuesday, as add-on therapy for the…